XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) Stock Fundamental Analysis
USA - NASDAQ:XOMAP - US98419J3059
26.0691 USD
-0.43 (-1.63%)
Taking everything into account, XOMAP scores 4 out of 10 in our fundamental rating. XOMAP was compared to 531 industry peers in the Biotechnology industry. While XOMAP is still in line with the averages on profitability rating, there are concerns on its financial health. XOMAP has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year XOMAP has reported negative net income.
In the past year XOMAP has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: XOMAP reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: XOMAP reported negative operating cash flow in multiple years.
1.2 Ratios
XOMAP has a Return On Assets of -7.93%. This is amongst the best in the industry. XOMAP outperforms 85.12% of its industry peers.
XOMAP has a better Return On Equity (-19.17%) than 84.18% of its industry peers.
XOMAP's Return On Invested Capital of 3.73% is amongst the best of the industry. XOMAP outperforms 91.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.93% | ||
| ROE | -19.17% | ||
| ROIC | 3.73% |
ROA(3y)-14.85%
ROA(5y)-6.52%
ROE(3y)-31.32%
ROE(5y)-15.58%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
XOMAP has a better Operating Margin (21.23%) than 95.29% of its industry peers.
XOMAP does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.23% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so XOMAP is destroying value.
The number of shares outstanding for XOMAP has been increased compared to 1 year ago.
The number of shares outstanding for XOMAP has been increased compared to 5 years ago.
XOMAP has a worse debt/assets ratio than last year.
2.2 Solvency
XOMAP has an Altman-Z score of -5.44. This is a bad value and indicates that XOMAP is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -5.44, XOMAP is not doing good in the industry: 61.96% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.11 is on the high side and indicates that XOMAP has dependencies on debt financing.
With a Debt to Equity ratio value of 1.11, XOMAP is not doing good in the industry: 77.21% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.44 |
ROIC/WACC0.42
WACC8.84%
2.3 Liquidity
A Current Ratio of 4.88 indicates that XOMAP has no problem at all paying its short term obligations.
XOMAP has a Current ratio (4.88) which is in line with its industry peers.
A Quick Ratio of 4.88 indicates that XOMAP has no problem at all paying its short term obligations.
XOMAP has a Quick ratio (4.88) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.88 | ||
| Quick Ratio | 4.88 |
3. Growth
3.1 Past
XOMAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.74%.
The Revenue has grown by 168.71% in the past year. This is a very strong growth!
The Revenue has been growing by 9.17% on average over the past years. This is quite good.
EPS 1Y (TTM)-38.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.62%
Revenue 1Y (TTM)168.71%
Revenue growth 3Y-9.28%
Revenue growth 5Y9.17%
Sales Q2Q%18.39%
3.2 Future
XOMAP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.32% yearly.
Based on estimates for the next years, XOMAP will show a very strong growth in Revenue. The Revenue will grow by 35.53% on average per year.
EPS Next Y126.86%
EPS Next 2Y49.97%
EPS Next 3Y37.32%
EPS Next 5YN/A
Revenue Next Year85%
Revenue Next 2Y45.1%
Revenue Next 3Y35.53%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
XOMAP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 50.79, the valuation of XOMAP can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XOMAP indicates a rather cheap valuation: XOMAP is cheaper than 89.64% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.73, XOMAP is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 50.79 |
4.2 Price Multiples
XOMAP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. XOMAP is cheaper than 91.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 31.17 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XOMAP's earnings are expected to grow with 37.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.97%
EPS Next 3Y37.32%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 8.14%, XOMAP is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 95.53, XOMAP pays a better dividend. On top of this XOMAP pays more dividend than 99.62% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, XOMAP pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 8.14% |
5.2 History
XOMAP has been paying a dividend for over 5 years, so it has already some track record.
XOMAP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of XOMAP are negative and hence is the payout ratio. XOMAP will probably not be able to sustain this dividend level.
DP-30.88%
EPS Next 2Y49.97%
EPS Next 3Y37.32%
XOMA ROYALTY CORP - XOMA 8 5/8 PERP
NASDAQ:XOMAP (11/10/2025, 9:40:02 AM)
26.0691
-0.43 (-1.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners68.05%
Inst Owner ChangeN/A
Ins Owners1.4%
Ins Owner ChangeN/A
Market Cap315.18M
Revenue(TTM)44.95M
Net Income(TTM)-17.72M
Analysts82
Price Target53.86 (106.6%)
Short Float %0.03%
Short Ratio2.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 8.14% |
Yearly Dividend0.47
Dividend Growth(5Y)N/A
DP-30.88%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)207.59%
Min EPS beat(2)119.7%
Max EPS beat(2)295.48%
EPS beat(4)2
Avg EPS beat(4)28.19%
Min EPS beat(4)-256.98%
Max EPS beat(4)295.48%
EPS beat(8)3
Avg EPS beat(8)57.63%
EPS beat(12)4
Avg EPS beat(12)26.41%
EPS beat(16)5
Avg EPS beat(16)-3.83%
Revenue beat(2)2
Avg Revenue beat(2)76.76%
Min Revenue beat(2)32.7%
Max Revenue beat(2)120.82%
Revenue beat(4)3
Avg Revenue beat(4)39.95%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)120.82%
Revenue beat(8)5
Avg Revenue beat(8)13.46%
Revenue beat(12)7
Avg Revenue beat(12)9.54%
Revenue beat(16)8
Avg Revenue beat(16)-1.84%
PT rev (1m)5.77%
PT rev (3m)-13.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)72.73%
EPS NY rev (1m)0%
EPS NY rev (3m)371.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)8.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)10.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 50.79 | ||
| P/S | 7.01 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.41 | ||
| P/tB | 6.7 | ||
| EV/EBITDA | 31.17 |
EPS(TTM)-1.54
EYN/A
EPS(NY)0.51
Fwd EY1.97%
FCF(TTM)-1.91
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS3.72
BVpS7.65
TBVpS3.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.93% | ||
| ROE | -19.17% | ||
| ROCE | 4.73% | ||
| ROIC | 3.73% | ||
| ROICexc | 6.38% | ||
| ROICexgc | 10.37% | ||
| OM | 21.23% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-14.85%
ROA(5y)-6.52%
ROE(3y)-31.32%
ROE(5y)-15.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.11 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.33 | ||
| Cap/Depr | 1425.07% | ||
| Cap/Sales | 44.89% | ||
| Interest Coverage | 0.78 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.88 | ||
| Quick Ratio | 4.88 | ||
| Altman-Z | -5.44 |
F-Score5
WACC8.84%
ROIC/WACC0.42
Cap/Depr(3y)7738.51%
Cap/Depr(5y)4653.1%
Cap/Sales(3y)108.05%
Cap/Sales(5y)64.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.62%
EPS Next Y126.86%
EPS Next 2Y49.97%
EPS Next 3Y37.32%
EPS Next 5YN/A
Revenue 1Y (TTM)168.71%
Revenue growth 3Y-9.28%
Revenue growth 5Y9.17%
Sales Q2Q%18.39%
Revenue Next Year85%
Revenue Next 2Y45.1%
Revenue Next 3Y35.53%
Revenue Next 5YN/A
EBIT growth 1Y141.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year177.34%
EBIT Next 3Y51.87%
EBIT Next 5YN/A
FCF growth 1Y34.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.47%
OCF growth 3YN/A
OCF growth 5YN/A
XOMA ROYALTY CORP - XOMA 8 5/8 PERP / XOMAP FAQ
What is the ChartMill fundamental rating of XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) stock?
ChartMill assigns a fundamental rating of 4 / 10 to XOMAP.
What is the valuation status for XOMAP stock?
ChartMill assigns a valuation rating of 4 / 10 to XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP). This can be considered as Fairly Valued.
What is the profitability of XOMAP stock?
XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) has a profitability rating of 4 / 10.
What is the expected EPS growth for XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) stock?
The Earnings per Share (EPS) of XOMA ROYALTY CORP - XOMA 8 5/8 PERP (XOMAP) is expected to grow by 126.86% in the next year.